# Spotlight Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/spotlight-medical

- Industry: Healthcare IT
- Headquarters: Paris, France
- Website: www.spotlightmedical.com
- Total disclosed funding: $6.6M
- Latest round: Seed (Jul 1, 2024)
- Investors on record: 2

## About

Founded in 2024 by co-founders Grégoire Gessain, Marvin Lerousseau, and Sylvain Berlemont and based in Paris, France, Spotlight Medical specialises in the development of artificial intelligence (AI)-driven prognosis tests designed to aid physicians in selecting personalized and effective treatment strategies for cancer patients. In July 2024, Spotlight Medical raised EUR 6.2 million, co-led by investors Kurma Partners and Heal Capital. Spotlight Medical's primary offering is its suite of AI-powered prognosis tests. These tests analyze patient data and predict the treatment plans tailored to individual patient profiles. By leveraging advanced machine learning algorithms, Spotlight Medical’s tests provide detailed insights that help clinicians make more informed decisions to improve patient outcomes and reduce treatment-related complications. The company will use the July 2024 funding to introduce its first prognostic test to the clinic to commercialize AI-based cancer therapy solutions.

## Funding rounds

- Seed, Jul 1, 2024, $6.6M — Kurma Partners, Heal Capital

## Investors

- Kurma Partners (https://capitalatlas.ai/funds/kurma-partners) — Seed
- Heal Capital (https://capitalatlas.ai/funds/heal-capital) — Seed